ADMA BIOLOGICS, INC. Revenues
ADMA BIOLOGICS, INC. (ADMA) reported Revenues of $16.05 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-12.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2021-05-12
- ADMA BIOLOGICS, INC. revenues for the quarter ending 2021-03-31 was $16.05M, a 57.34% increase year-over-year.
- ADMA BIOLOGICS, INC. revenues for the quarter ending 2020-12-31 was $13.96M, a 15.94% increase year-over-year.
- ADMA BIOLOGICS, INC. revenues for the quarter ending 2020-09-30 was $10.28M, a 42.28% increase year-over-year.
- ADMA BIOLOGICS, INC. revenues for the quarter ending 2020-06-30 was $7.79M, a 18.70% increase year-over-year.
- ADMA BIOLOGICS, INC. revenues for fiscal 2020 was $42.22M, a 43.85% increase from fiscal 2019.
- ADMA BIOLOGICS, INC. revenues for fiscal 2019 was $29.35M, a 72.79% increase from fiscal 2018.
- ADMA BIOLOGICS, INC. revenues for fiscal 2018 was $16.99M, a 25.37% decline from fiscal 2017.
- ADMA BIOLOGICS, INC. revenues for fiscal 2017 was $22.76M, a 113.49% increase from fiscal 2016.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|---|
| 2021-03-31 | $16.05M 10-Q · filed 2021-05-12 | $30.00M derived: sum of 2 quarters · filed 2021-05-12 | $40.28M derived: sum of 3 quarters · filed 2021-05-12 | $48.07M derived: sum of 4 quarters · filed 2021-05-12 | |
| 2020-12-31 | $13.96M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $24.23M derived: sum of 2 quarters · filed 2021-03-25 | $32.02M derived: sum of 3 quarters · filed 2021-03-25 | $42.22M 10-K · filed 2021-03-25 | |
| 2020-09-30 | $10.28M 10-Q · filed 2020-11-05 | $18.06M derived: sum of 2 quarters · filed 2020-11-05 | $28.26M 10-Q · filed 2020-11-05 | $40.30M derived: sum of 4 quarters · filed 2021-05-12 | |
| 2020-06-30 | $7.79M 10-Q · filed 2020-08-05 | $17.99M 10-Q · filed 2020-08-05 | $30.02M derived: sum of 3 quarters · filed 2021-05-12 | $37.25M derived: sum of 4 quarters · filed 2021-05-12 | |
| 2020-03-31 | $10.20M 10-Q · filed 2021-05-12 | $22.24M derived: sum of 2 quarters · filed 2021-05-12 | $29.46M derived: sum of 3 quarters · filed 2021-05-12 | $36.02M derived: sum of 4 quarters · filed 2021-05-12 | |
| 2019-12-31 | $12.04M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $19.26M derived: sum of 2 quarters · filed 2021-03-25 | $25.82M derived: sum of 3 quarters · filed 2021-03-25 | $29.35M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $7.22M 10-Q · filed 2020-11-05 | $13.78M derived: sum of 2 quarters · filed 2020-11-05 | $17.31M 10-Q · filed 2020-11-05 | $21.37M derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | $6.56M 10-Q · filed 2020-08-05 | $10.09M 10-Q · filed 2020-08-05 | $14.15M derived: sum of 3 quarters · filed 2020-08-05 | $18.38M derived: sum of 4 quarters · filed 2020-08-05 | |
| 2019-03-31 | $3.53M 10-Q · filed 2020-05-06 | $7.59M derived: sum of 2 quarters · filed 2020-05-06 | $11.82M derived: sum of 3 quarters · filed 2020-05-06 | $16.47M derived: sum of 4 quarters · filed 2020-05-06 | |
| 2018-12-31 | $4.06M 10-K · filed 2019-03-13 | $8.29M derived: sum of 2 quarters · filed 2019-11-06 | $12.94M derived: sum of 3 quarters · filed 2019-11-06 | $16.99M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $4.23M 10-Q · filed 2019-11-06 | $8.89M derived: sum of 2 quarters · filed 2019-11-06 | $12.93M 10-Q · filed 2019-11-06 | $24.93M derived: sum of 4 quarters · filed 2019-11-06 | |
| 2018-06-30 | $4.66M 10-Q · filed 2019-08-08 | $8.70M 10-Q · filed 2019-08-08 | $20.70M derived: sum of 3 quarters · filed 2019-08-08 | $25.43M derived: sum of 4 quarters · filed 2019-08-08 | |
| 2018-03-31 | $4.04M 10-Q · filed 2019-05-08 | $16.04M derived: sum of 2 quarters · filed 2019-05-08 | $20.77M derived: sum of 3 quarters · filed 2019-05-08 | $24.17M derived: sum of 4 quarters · filed 2019-05-08 | |
| 2017-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $16.73M derived: sum of 2 quarters · filed 2019-03-13 | $20.13M derived: sum of 3 quarters · filed 2019-03-13 | $22.76M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $4.73M 10-Q · filed 2018-11-09 | $8.13M derived: sum of 2 quarters · filed 2018-11-09 | $10.76M 10-Q · filed 2018-11-09 | $14.09M derived: sum of 4 quarters · filed 2018-11-09 | |
| 2017-06-30 | $3.40M 10-Q · filed 2018-08-10 | $6.03M 10-Q · filed 2018-08-10 | $9.36M derived: sum of 3 quarters · filed 2018-08-10 | $12.29M derived: sum of 4 quarters · filed 2018-08-10 | |
| 2017-03-31 | $2.63M 10-Q · filed 2018-05-14 | $5.96M derived: sum of 2 quarters · filed 2018-05-14 | $8.89M derived: sum of 3 quarters · filed 2018-05-14 | $11.17M derived: sum of 4 quarters · filed 2018-05-14 | |
| 2016-12-31 | $3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $6.27M derived: sum of 2 quarters · filed 2018-03-29 | $8.54M derived: sum of 3 quarters · filed 2018-03-29 | $10.66M 10-K · filed 2018-03-29 | |
| 2016-09-30 | $2.94M 10-Q · filed 2017-11-03 | $5.21M derived: sum of 2 quarters · filed 2017-11-03 | $7.33M 10-Q · filed 2017-11-03 | $9.85M derived: sum of 4 quarters · filed 2017-11-03 | |
| 2016-06-30 | $2.27M 10-Q · filed 2017-08-11 | $4.40M 10-Q · filed 2017-08-11 | $6.91M derived: sum of 3 quarters · filed 2017-08-11 | $8.76M derived: sum of 4 quarters · filed 2017-08-11 | |
| 2016-03-31 | $2.12M 10-Q · filed 2017-05-12 | $4.64M derived: sum of 2 quarters · filed 2017-05-12 | $6.49M derived: sum of 3 quarters · filed 2017-05-12 | $7.80M derived: sum of 4 quarters · filed 2017-05-12 | |
| 2015-12-31 | $2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $4.36M derived: sum of 2 quarters · filed 2017-02-24 | $5.67M derived: sum of 3 quarters · filed 2017-02-24 | $7.18M 10-K · filed 2017-02-24 | |
| 2015-09-30 | $1.85M 10-Q · filed 2016-11-10 | $3.16M derived: sum of 2 quarters · filed 2016-11-10 | $4.67M 10-Q · filed 2016-11-10 | $6.15M derived: sum of 4 quarters · filed 2016-11-10 | |
| 2015-06-30 | $1.31M 10-Q · filed 2016-08-12 | $2.81M 10-Q · filed 2016-08-12 | $4.30M derived: sum of 3 quarters · filed 2016-08-12 | $5.67M derived: sum of 4 quarters · filed 2016-08-12 | |
| 2015-03-31 | $1.50M 10-Q · filed 2016-05-13 | $2.99M derived: sum of 2 quarters · filed 2016-05-13 | $4.36M derived: sum of 3 quarters · filed 2016-05-13 | $5.86M derived: sum of 4 quarters · filed 2016-05-13 | |
| 2014-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | $2.85M derived: sum of 2 quarters · filed 2016-03-23 | $4.35M derived: sum of 3 quarters · filed 2016-03-23 | $5.92M 10-K · filed 2016-03-23 | |
| 2014-09-30 | $1.37M 10-Q · filed 2015-11-10 | $2.87M derived: sum of 2 quarters · filed 2015-11-10 | $4.43M 10-Q · filed 2015-11-10 | $4.85M derived: sum of 4 quarters · filed 2015-11-10 | |
| 2014-06-30 | $1.50M 10-Q · filed 2015-08-11 | $3.06M 10-Q · filed 2015-08-11 | $3.48M derived: sum of 3 quarters · filed 2015-08-11 | $4.59M derived: sum of 4 quarters · filed 2015-08-11 | |
| 2014-03-31 | $1.56M 10-Q · filed 2015-05-12 | $1.54M 10-Q · filed 2014-05-12 | $1.98M derived: sum of 2 quarters · filed 2015-05-12 | $3.09M derived: sum of 3 quarters · filed 2015-05-12 | $3.84M derived: sum of 4 quarters · filed 2015-05-12 |
| 2013-12-31 | $424.03K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $1.53M derived: sum of 2 quarters · filed 2015-03-09 | $2.27M derived: sum of 3 quarters · filed 2015-03-09 | $3.07M 10-K · filed 2015-03-09 | |
| 2013-09-30 | $1.11M 10-Q · filed 2014-11-10 | $1.85M derived: sum of 2 quarters · filed 2014-11-10 | $2.64M 10-Q · filed 2014-11-10 | $3.17M derived: sum of 4 quarters · filed 2014-11-10 | |
| 2013-06-30 | $743.27K 10-Q · filed 2014-08-11 | $1.54M 10-Q · filed 2014-08-11 | $2.06M derived: sum of 3 quarters · filed 2014-08-11 | $2.42M derived: sum of 4 quarters · filed 2014-08-11 | |
| 2013-03-31 | $792.93K 10-Q · filed 2014-05-12 | $1.32M derived: sum of 2 quarters · filed 2014-05-12 | $1.68M derived: sum of 3 quarters · filed 2014-05-12 | $1.91M derived: sum of 4 quarters · filed 2014-05-12 | |
| 2012-12-31 | $523.28K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $883.62K derived: sum of 2 quarters · filed 2014-03-28 | $1.11M derived: sum of 3 quarters · filed 2014-03-28 | $1.12M 10-K · filed 2014-03-28 | |
| 2012-09-30 | $360.34K 10-Q · filed 2013-11-12 | $590.43K derived: sum of 2 quarters · filed 2013-11-12 | $594.83K 10-Q · filed 2013-11-12 | $1.36M derived: sum of 4 quarters · filed 2013-11-12 | |
| 2012-06-30 | $230.10K 10-Q · filed 2013-08-12 | $234.50K 10-Q · filed 2013-08-12 | $995.54K derived: sum of 3 quarters · filed 2013-08-12 | $995.54K derived: sum of 4 quarters · filed 2013-08-12 | |
| 2012-03-31 | $4.40K 10-Q · filed 2013-05-14 | $765.44K derived: sum of 2 quarters · filed 2013-05-14 | $765.44K derived: sum of 3 quarters · filed 2013-05-14 | ||
| 2011-12-31 | $761.04K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-06 | $761.04K derived: sum of 2 quarters · filed 2013-03-06 | $761.04K 10-K · filed 2013-03-06 | ||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-13 | $0.00 10-Q · filed 2012-11-13 | |||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |